MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
$4,396,456
EPS
$0.07
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
General and administrative costs
112,227
132,030
21,846
155,513
Total operating expenses
112,227
132,030
21,846
-
Loss from operations
-112,227
-132,030
-21,846*
-155,513
Interest earned on cash and investments held in trust account
4,508,683
4,439,850
4,411,961.25*
109,355
Gain on extinguishment of over-allotment option liability
-
-
138,437*
-
Provision for credit losses
-
-
203,028.25*
-
Recovery of credit losses
-
-30,000
-
-
Total other income
4,508,683
4,469,850
4,347,370*
109,355
Net income (loss)
4,396,456
4,337,820
4,325,524
-46,158
Basic EPS
0.07
0.07
0.181
0
Diluted EPS
0.07
0.07
0.181
0
Basic Average Shares
50,000,000
50,000,000
23,857,951
2,717,391
Diluted Average Shares
13,700,000
50,000,000
23,857,951
2,717,391
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Interest earned on cash
and investments...
$4,508,683
Total other income
$4,508,683
Net income (loss)
$4,396,456
Loss from operations
-$112,227
Total operating
expenses
$112,227
General and
administrative costs
$112,227
Buy us a coffee
Drugs Made In America Acquisition II Corp. (DMII)
Drugs Made In America Acquisition II Corp. (DMII)